Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -96.44%210.4M | -92.72%731.64M | -91.62%953.66M | -82.75%2.28B | -51.26%5.91B | -18.32%10.05B | -17.23%11.39B | 10.74%13.23B | -13.40%12.12B | -5.53%12.31B |
| Transactional financial assets | 4.11%38.79M | 0.29%42.52M | -6.39%36.69M | -12.18%36.71M | -19.52%37.26M | -11.13%42.4M | -22.28%39.2M | -21.17%41.8M | -38.03%46.29M | 9.04%47.71M |
| Notes receivable and accounts receivable | -18.73%1.54B | -51.02%1.73B | -53.44%1.7B | -62.07%1.15B | -35.69%1.89B | 30.25%3.54B | 23.63%3.64B | -2.09%3.04B | -8.47%2.94B | -33.80%2.72B |
| -Notes receivable | 56.72%793.94M | 4.30%851.75M | 13.34%765M | -99.98%100K | 23.08%506.61M | --816.66M | --674.96M | --446.64M | --411.6M | ---- |
| -Accounts receivable | -46.34%742.74M | -67.60%882.45M | -68.63%930.73M | -55.55%1.15B | -45.25%1.38B | 0.21%2.72B | 0.72%2.97B | -16.47%2.6B | -21.29%2.53B | -17.03%2.72B |
| Other receivables (including interest and dividends) | -72.15%302.07M | -68.60%658.09M | -60.21%826.49M | -54.07%968.73M | -51.25%1.08B | 4.06%2.1B | 26.19%2.08B | 24.46%2.11B | 29.55%2.22B | -10.93%2.01B |
| -Dividend receivable | ---- | ---- | ---- | --22.66M | --22.66M | --24.43M | --22.66M | ---- | ---- | ---- |
| -Other receivable | -71.56%302.07M | ---- | -59.77%826.49M | ---- | -52.27%1.06B | ---- | 24.81%2.05B | ---- | 29.55%2.22B | ---- |
| Advance payment | -55.38%281.93M | -41.60%565.65M | -45.68%514.71M | -23.87%644.8M | -23.42%631.89M | -0.61%968.55M | 11.87%947.49M | -1.15%846.99M | 4.69%825.14M | -1.26%974.47M |
| Inventories | 16.96%3.32B | -33.17%2.68B | -40.81%2.52B | -42.41%2.9B | -42.81%2.84B | -27.50%4.01B | -37.12%4.26B | -29.28%5.03B | -27.32%4.96B | 5.41%5.54B |
| Receivable financing | -64.28%35.98M | -69.48%22.98M | 317.69%92.17M | -70.09%75.85M | -53.34%100.73M | -86.65%75.28M | -96.41%22.07M | -73.94%253.62M | -76.66%215.88M | -75.36%563.94M |
| Non-current assets due within one year | -93.16%194.2M | -49.92%1.84B | -40.01%2.39B | -33.53%2.62B | -31.75%2.84B | -2.92%3.68B | 3.58%3.99B | -1.23%3.94B | 4.08%4.16B | -29.49%3.79B |
| Other current assets | -54.94%252.3M | -77.61%246.58M | -70.61%337.59M | -59.94%454M | -47.61%559.91M | 7.11%1.1B | -1.04%1.15B | -4.24%1.13B | -9.48%1.07B | -20.73%1.03B |
| Total current assets | -61.18%6.17B | -66.65%8.53B | -65.93%9.37B | -62.43%11.13B | -44.37%15.89B | -11.77%25.57B | -13.07%27.51B | -4.18%29.63B | -12.69%28.57B | -16.34%28.98B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -56.34%327.93M | -55.89%344.06M | -55.87%344.27M | -55.95%344.27M | -3.91%751.03M | -0.67%780.08M | -0.67%780.08M | -0.66%781.56M | -0.66%781.56M | 0.31%785.37M |
| Investment real estate | -5.94%5.4B | -7.45%5.46B | -7.45%5.5B | -5.14%5.69B | -5.06%5.74B | -3.30%5.9B | -3.39%5.95B | -3.26%6B | -3.32%6.05B | -3.33%6.1B |
| Long-term equity investment | -47.22%2.1B | -28.57%3.33B | -22.12%3.62B | -15.95%3.93B | -15.24%3.97B | -3.51%4.66B | 6.77%4.65B | 9.10%4.68B | 9.54%4.69B | 149.93%4.83B |
| Long term receivable account | 734.35%2.34B | -37.86%331.74M | -30.92%385.12M | -50.54%325.63M | -17.39%280.29M | -59.37%533.85M | -59.38%557.47M | -54.39%658.33M | -77.18%339.29M | -18.19%1.31B |
| Fixed assets | -8.27%29.22B | ---- | -4.82%30.49B | ---- | -4.01%31.86B | ---- | -2.07%32.03B | ---- | -1.02%33.19B | ---- |
| Constru in process | 5.65%619.78M | ---- | -44.69%604.01M | ---- | -31.16%586.61M | ---- | 63.83%1.09B | ---- | 54.65%852.14M | ---- |
| Construction materials | -5.07%6.86M | ---- | -5.24%6.86M | ---- | -3.37%7.23M | ---- | -7.79%7.24M | ---- | -4.68%7.48M | ---- |
| Productive biological assets | -79.97%1.87M | -48.96%9.38M | -47.76%9.38M | -47.12%9.35M | -47.12%9.35M | 7.35%18.38M | 7.04%17.96M | 11.03%17.68M | 29.11%17.68M | 42.55%17.12M |
| Intangible assets | -2.92%1.6B | -16.69%1.62B | -16.78%1.63B | -15.83%1.64B | -17.48%1.65B | 0.40%1.94B | 6.35%1.95B | 5.66%1.95B | 9.34%2B | 3.00%1.93B |
| Goodwill | ---- | ---- | ---- | ---- | ---- | -76.51%8.27M | -76.51%8.27M | -69.30%8.27M | 30.70%35.22M | 30.70%35.22M |
| Long deferred expense | -19.77%232.4M | 552.09%246.08M | 587.38%262.08M | 610.07%275.6M | 624.57%289.68M | -7.48%37.74M | -8.96%38.13M | -10.37%38.81M | -10.08%39.98M | -11.52%40.79M |
| Deferred tax assets | 13.48%2.03B | -4.05%1.9B | -1.56%1.79B | 16.30%2.04B | 5.96%1.79B | 25.35%1.98B | 16.17%1.81B | 26.35%1.75B | 26.51%1.69B | 27.25%1.58B |
| Usufruct assets | -43.13%151.3M | 57.78%253.31M | 58.01%256.6M | 58.27%262.49M | 58.52%266.02M | -7.03%160.54M | -7.25%162.39M | -7.77%165.85M | -7.60%167.82M | -6.86%172.69M |
| Other non current assets | 0.77%419.08M | -53.28%433.32M | -53.28%433.32M | -56.08%433.32M | -61.03%415.86M | -8.69%927.54M | -8.67%927.56M | 2.22%986.66M | 8.45%1.07B | 12.91%1.02B |
| Total non current assets | -6.65%44.45B | -10.67%44.33B | -9.32%45.33B | -7.21%46.89B | -6.49%47.62B | -2.40%49.62B | -1.99%49.99B | -1.20%50.53B | -1.28%50.92B | 2.57%50.84B |
| Total assets | -20.29%50.62B | -29.71%52.85B | -29.42%54.7B | -27.62%58.02B | -20.10%63.51B | -5.80%75.19B | -6.23%77.5B | -2.32%80.17B | -5.71%79.49B | -5.21%79.83B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -20.73%21.23B | -22.27%23.31B | -22.93%23.33B | -30.79%23.64B | -20.00%26.78B | -10.38%29.99B | -13.40%30.26B | -1.90%34.16B | -8.00%33.48B | -6.89%33.47B |
| Notes payable and accounts payable | -5.74%8.61B | -7.53%8.3B | -11.47%8.53B | -2.01%8.7B | 7.17%9.13B | 10.06%8.97B | 28.48%9.64B | 21.20%8.88B | 17.64%8.52B | 26.20%8.15B |
| -Notes payable | ---- | -99.00%53.73M | -98.07%107.37M | -93.14%333.45M | -69.17%1.42B | 37.11%5.36B | 57.54%5.56B | 45.67%4.86B | 47.64%4.62B | 16.17%3.91B |
| -Accounts payable | 11.67%8.61B | 128.40%8.24B | 106.68%8.43B | 108.45%8.37B | 97.53%7.71B | -14.89%3.61B | 2.65%4.08B | 0.70%4.01B | -5.16%3.9B | 37.12%4.24B |
| Contract liabilities | 7.81%296.3M | -56.84%485.14M | -87.52%189.32M | -82.54%259.3M | -80.96%274.83M | -20.55%1.12B | -6.87%1.52B | -5.89%1.48B | 10.54%1.44B | 8.96%1.41B |
| Advance receipts | 13.55%61.93M | 79.77%41.8M | 234.10%48.11M | 283.68%48.83M | 235.77%54.54M | -17.58%23.25M | 11.10%14.4M | -21.43%12.73M | 13.89%16.24M | -39.75%28.21M |
| Salaries payable | 47.02%369.59M | 195.55%349.19M | 596.00%314.06M | 231.88%237.47M | 238.17%251.39M | 18.56%118.15M | -60.69%45.12M | -47.11%71.55M | -48.71%74.34M | -26.32%99.66M |
| Taxs payable | 5.04%203.17M | 69.11%197.55M | 43.93%168.78M | 124.92%200.18M | 93.99%193.42M | -56.90%116.82M | -12.57%117.27M | -29.05%89M | -61.80%99.71M | 38.82%271.03M |
| Other payable (including interest and dividends) | 64.76%4.77B | 19.32%4.07B | 9.29%3.56B | 41.04%3.43B | 19.95%2.9B | 68.74%3.41B | 58.20%3.26B | 20.27%2.44B | 29.10%2.41B | -4.39%2.02B |
| -Interest payable | 580.07%428.73M | --345.62M | --248.73M | --185.36M | --63.04M | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | 79.26%220.49M | 82.32%224.25M | -20.74%97.49M | --123M | --123M | --123M | --123M | ---- | ---- | ---- |
| -Other payable | 52.11%4.12B | --3.5B | 2.54%3.21B | --3.13B | 12.24%2.71B | ---- | 52.23%3.13B | ---- | 30.21%2.41B | ---- |
| Non current liabilities due within one year | 46.59%2.31B | 4.96%2.96B | -26.46%2.53B | -31.44%2.54B | -56.55%1.58B | -29.92%2.82B | -17.00%3.45B | -15.93%3.7B | -22.29%3.63B | -6.88%4.03B |
| Other current liabilities | -42.57%1.54B | 427.18%369.02M | 1,106.20%844.34M | 1,707.57%1.81B | 2,580.56%2.68B | --70M | --70M | --100M | --100M | ---- |
| Total current liabilities | -10.15%39.39B | -14.07%40.09B | -18.30%39.52B | -19.76%40.86B | -11.92%43.84B | -5.72%46.65B | -4.31%48.37B | 1.00%50.92B | -4.09%49.78B | -2.05%49.48B |
| Current liabilities | ||||||||||
| Long term loan | 17.06%5.58B | -32.71%3.55B | -23.27%3.7B | -13.18%3.93B | 1.77%4.76B | 14.25%5.28B | -1.45%4.82B | 18.34%4.52B | 17.55%4.68B | -7.01%4.62B |
| Long term account payable | 117.48%1.69B | ---- | 11.65%2.54B | ---- | -69.50%774.97M | ---- | -19.74%2.28B | ---- | -19.61%2.54B | ---- |
| Estimate liabilities | 375.74%28.23M | --5.94M | --5.94M | --5.94M | --5.94M | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -34.07%5.67M | -11.76%4.55M | -11.43%4.7M | -19.72%4.38M | -9.42%8.6M | -61.79%5.16M | -61.10%5.31M | -33.25%5.46M | 16.00%9.49M | 7.48%13.5M |
| Long term deferred income | -12.60%1.08B | -7.80%1.16B | -7.63%1.19B | -7.63%1.22B | -7.24%1.24B | -7.28%1.26B | -7.14%1.29B | -8.83%1.32B | -8.94%1.34B | -8.95%1.36B |
| Lease liabilities | -7.39%34.35M | -9.67%36.46M | -9.67%36.46M | -11.66%37.09M | -11.66%37.09M | -18.11%40.36M | -18.11%40.36M | -21.66%41.99M | -21.66%41.99M | -17.13%49.29M |
| Total non current liabilities | 23.18%8.41B | -13.92%7.42B | -11.31%7.48B | -17.84%6.88B | -20.67%6.83B | -1.74%8.62B | -8.14%8.44B | 2.44%8.38B | -0.72%8.61B | -11.68%8.77B |
| Total liabilities | -5.66%47.81B | -14.05%47.51B | -17.26%47B | -19.49%47.74B | -13.21%50.67B | -5.12%55.27B | -4.90%56.81B | 1.20%59.3B | -3.60%58.39B | -3.63%58.26B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%2.93B | -0.75%2.93B | -0.75%2.93B | -0.75%2.93B | -0.75%2.93B | -0.77%2.96B | -0.77%2.96B | -0.77%2.96B | -0.77%2.96B | 0.00%2.98B |
| Capital reserve funds | 0.65%5.24B | -0.17%5.24B | -0.17%5.24B | -1.01%5.21B | -2.27%5.21B | -2.24%5.25B | -1.56%5.25B | -1.94%5.26B | -0.60%5.33B | 0.20%5.37B |
| Surplus reserve funds | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B | 0.00%1.21B |
| Retained profit | -1,362.75%-7.68B | -173.87%-5.4B | -140.38%-3.25B | -110.45%-843.82M | -92.42%607.82M | -14.33%7.31B | -7.51%8.05B | -11.37%8.08B | -14.59%8.02B | -9.63%8.53B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | -50.74%63.43M | -50.74%63.43M | -50.74%63.43M | -50.74%63.43M | 0.00%128.78M |
| Other composite income | -0.18%-915.39M | -10.52%-903.2M | -5.60%-929.73M | -5.08%-913.86M | -5.65%-913.71M | 9.09%-817.24M | 3.00%-880.42M | -7.06%-869.64M | -5.22%-864.88M | -18.42%-898.94M |
| Ordinary risk reserve funds | -15.94%68.05M | 1.97%80.95M | 1.97%80.95M | 1.99%80.95M | 1.99%80.95M | -0.65%79.38M | -0.65%79.38M | -0.71%79.37M | -0.66%79.37M | 0.08%79.9M |
| Specific reserves | 43.82%38.54M | 19.86%31.3M | 17.22%29.83M | 15.27%28.43M | 14.91%26.8M | 21.70%26.11M | 27.79%25.45M | 55.72%24.66M | 47.69%23.32M | --21.46M |
| Shareholders equity without minority interests | -90.13%903.84M | -79.96%3.2B | -68.01%5.32B | -53.80%7.71B | -45.15%9.16B | -7.07%15.95B | -9.07%16.63B | -11.39%16.68B | -12.54%16.69B | -10.49%17.17B |
| Minority interests | -48.11%1.91B | -45.84%2.15B | -41.50%2.38B | -38.52%2.57B | -16.48%3.68B | -9.86%3.97B | -12.22%4.06B | -9.97%4.19B | -5.13%4.41B | -3.87%4.4B |
| Total shareholder equity | -78.08%2.81B | -73.17%5.34B | -62.81%7.7B | -50.73%10.28B | -39.16%12.84B | -7.64%19.92B | -9.70%20.69B | -11.11%20.87B | -11.09%21.1B | -9.22%21.57B |
| Total liabilityies and equity | -20.29%50.62B | -29.71%52.85B | -29.42%54.7B | -27.62%58.02B | -20.10%63.51B | -5.80%75.19B | -6.23%77.5B | -2.32%80.17B | -5.71%79.49B | -5.21%79.83B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Adverse Opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.